Home › NCT03154697
Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances
RecruitingObservational study
Development of Clinical Database of Individuals With Smith-Magenis Syndrome
Who can join
Ages 3 to 65 · All sexes
Full eligibility criteria
Inclusion Criteria: * Parent or legal guardian of individual with Smith-Magenis Syndrome Exclusion Criteria: * Not legal guardian of individual with SMS
About the study
This database will be used to better understand the sleep problems of people with SMS. This clinical database will be a part of a larger Smith-Magenis Patient Registry used to create an awareness campaign around SMS and the sleep disturbances that are characteristic of the disorder.
What is being tested
- Data collection of sleep disturbances in individuals with SMS (other)
Sponsor: Vanda Pharmaceuticals · Participants: 1,000 · Started: 2016-01
Contact the study team
- Vanda Pharmaceuticals · Phone: 202-734-3400
Official record on ClinicalTrials.gov — NCT03154697
Locations in the U.S.
| District of Columbia | Vanda Pharmaceuticals, Washington D.C. |
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.